NASDAQ: PRE - Prenetics Global Limited

Yield per half year: +41.67%
Sector: Healthcare

Share chart Prenetics Global Limited


About

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use.

More details
The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

Main settings

Выручка 0.0092
EBITDA -0.0185
Число акций ао 0.01125 млрд
P/S 4.92
P/BV -3.38
EV/EBITDA 0.5737
Цена ао 3.56
ISIN KYG722451062
Сайт https://www.prenetics.com
Change price per day: +3.3% (5.76)
Change price per week: +3.12% (5.7701)
Change price per month: +33.71% (4.45)
Change price per 3 month: +20.93% (4.92)
Change price per half year: +41.67% (4.2)
Change price per year: +583.91% (0.87)
Change price per year to date: +0.6768% (5.91)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 4.92 6
P/BV -3.38 10
P/E 0 0
EV/EBITDA 0.5737 0
Total:

Efficiency

Title Value Grade
ROA, % -22.32 0
ROE, % -28.29 0
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA -0.0537 10
Total:

Growth impulse

Title Value Grade
Profit growth, % 96.04 10
Share price growth, % 0 0
Dividend growth, % 0 0
Total:

Main owners

Institutions Volume Share, %
Prudential PLC 684822 6.45
Aspex Management (HK) Ltd 346150 3.26
Nomura Holdings Inc. 193963 1.83
Aspire Private Capital, LLC 114 0
Bank of America Corporation 111 0
Wolverine Asset Management, LLC 1 0

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Hoi Chun Lo Chief Financial Officer N/A 1985 (39 years)
Dr. Yung Ho Wong DPHIL Chief Technology Officer N/A 1982 (42 years)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President, People & Operations N/A
Dr. Senthil Sundaram M.D. Chief Clinical Officer N/A 1974 (50 years)
Mr. Joel Neoh Chief Consumer Officer & Chief Executive Officer for CircleDNA N/A 1984 (40 years)
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO N/A 1979 (45 years)
Dr. Chi Hung Tzang Ph.D. Co-Founder, Chief Scientific Officer & Member of Scientific Advisory Board N/A 1975 (49 years)
Mr. Walt Ling Chief Executive Officer of ACT Genomics N/A

About company

Address: Hong Kong, Quarry Bay, Unit 701-706. K11 Atelier King’s Road - open in Google maps, open in Yandex maps
Website: https://www.prenetics.com
Phone: +tel:85222109588